3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia
3
Squamous Cell Carcinoma of Head and Neck
1
Meningioma
1
Lung Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Interventions
Temozolomide
16
Radiotherapy
7
apatinib
5
anlotinib
3
Surgical Procedures, Operative
3
Chlorotoxin
3
Bevacizumab
3
Aminolevulinic Acid
3
Positron Emission Tomography Computed Tomography
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Irinotecan
2
Immunotherapy, Adoptive
2
Blood Specimen Collection
2
vandetanib
1
sodium thiosulfate
1
ribociclib
1
poly ICLC
1
lonafarnib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
etoposide phosphate
1
Vinblastine
1
Valproic Acid
1
Tranexamic Acid
1
Surveys and Questionnaires
1
Sunitinib
1
Rivaroxaban
1
Radiosurgery
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glioma
×
Hydroxyurea
×
Clear all
NCT03463733
2020-10-08
HUTMZ
Amsterdam UMC, location VUmc
Phase 1
Unknown
54 enrolled